The role of the cerebellum in the pathophysiology of Parkinson's disease

Mechelle M. Lewis, Shawna Galley, Samantha Johnson, James Stevenson, Xuemei Huang, Martin J. McKeown

Research output: Contribution to journalReview article

20 Citations (Scopus)

Abstract

Parkinson's disease (PD), the most common neurodegenerative movement disorder, has traditionally been considered a "classic" basal ganglia disease, as the most obvious pathology is seen in the dopaminergic cells in the substantia nigra pars compacta. Nevertheless recent discoveries in anatomical connections linking the basal ganglia and the cerebellum have led to a re-examination of the role of the cerebellum in the pathophysiology of PD. This review summarizes the role of the cerebellum in explaining many curious features of PD: the significant variation in disease progression between individuals; why severity of dopaminergic deficit correlates with many features of PD such as bradykinesia, but not tremor; and why PD subjects with a tremor-predominant presentation tend to have a more benign prognosis. It is clear that the cerebellum participates in compensatory mechanisms associated with the disease and must be considered an essential contributor to the overall pathophysiology of PD.

Original languageEnglish (US)
Pages (from-to)299-306
Number of pages8
JournalThe Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
Volume40
Issue number3
DOIs
StatePublished - May 1 2013

Fingerprint

Cerebellum
Parkinson Disease
Tremor
Basal Ganglia Diseases
Hypokinesia
Movement Disorders
Basal Ganglia
Neurodegenerative Diseases
Disease Progression
Pathology

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Cite this

@article{13f1bb0fc10d4fcf9cda203d0558bf49,
title = "The role of the cerebellum in the pathophysiology of Parkinson's disease",
abstract = "Parkinson's disease (PD), the most common neurodegenerative movement disorder, has traditionally been considered a {"}classic{"} basal ganglia disease, as the most obvious pathology is seen in the dopaminergic cells in the substantia nigra pars compacta. Nevertheless recent discoveries in anatomical connections linking the basal ganglia and the cerebellum have led to a re-examination of the role of the cerebellum in the pathophysiology of PD. This review summarizes the role of the cerebellum in explaining many curious features of PD: the significant variation in disease progression between individuals; why severity of dopaminergic deficit correlates with many features of PD such as bradykinesia, but not tremor; and why PD subjects with a tremor-predominant presentation tend to have a more benign prognosis. It is clear that the cerebellum participates in compensatory mechanisms associated with the disease and must be considered an essential contributor to the overall pathophysiology of PD.",
author = "Lewis, {Mechelle M.} and Shawna Galley and Samantha Johnson and James Stevenson and Xuemei Huang and McKeown, {Martin J.}",
year = "2013",
month = "5",
day = "1",
doi = "10.1017/S0317167100014232",
language = "English (US)",
volume = "40",
pages = "299--306",
journal = "Canadian Journal of Neurological Sciences",
issn = "0317-1671",
publisher = "Canadian Journal of Neurological Sciences",
number = "3",

}

The role of the cerebellum in the pathophysiology of Parkinson's disease. / Lewis, Mechelle M.; Galley, Shawna; Johnson, Samantha; Stevenson, James; Huang, Xuemei; McKeown, Martin J.

In: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, Vol. 40, No. 3, 01.05.2013, p. 299-306.

Research output: Contribution to journalReview article

TY - JOUR

T1 - The role of the cerebellum in the pathophysiology of Parkinson's disease

AU - Lewis, Mechelle M.

AU - Galley, Shawna

AU - Johnson, Samantha

AU - Stevenson, James

AU - Huang, Xuemei

AU - McKeown, Martin J.

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Parkinson's disease (PD), the most common neurodegenerative movement disorder, has traditionally been considered a "classic" basal ganglia disease, as the most obvious pathology is seen in the dopaminergic cells in the substantia nigra pars compacta. Nevertheless recent discoveries in anatomical connections linking the basal ganglia and the cerebellum have led to a re-examination of the role of the cerebellum in the pathophysiology of PD. This review summarizes the role of the cerebellum in explaining many curious features of PD: the significant variation in disease progression between individuals; why severity of dopaminergic deficit correlates with many features of PD such as bradykinesia, but not tremor; and why PD subjects with a tremor-predominant presentation tend to have a more benign prognosis. It is clear that the cerebellum participates in compensatory mechanisms associated with the disease and must be considered an essential contributor to the overall pathophysiology of PD.

AB - Parkinson's disease (PD), the most common neurodegenerative movement disorder, has traditionally been considered a "classic" basal ganglia disease, as the most obvious pathology is seen in the dopaminergic cells in the substantia nigra pars compacta. Nevertheless recent discoveries in anatomical connections linking the basal ganglia and the cerebellum have led to a re-examination of the role of the cerebellum in the pathophysiology of PD. This review summarizes the role of the cerebellum in explaining many curious features of PD: the significant variation in disease progression between individuals; why severity of dopaminergic deficit correlates with many features of PD such as bradykinesia, but not tremor; and why PD subjects with a tremor-predominant presentation tend to have a more benign prognosis. It is clear that the cerebellum participates in compensatory mechanisms associated with the disease and must be considered an essential contributor to the overall pathophysiology of PD.

UR - http://www.scopus.com/inward/record.url?scp=84893334996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893334996&partnerID=8YFLogxK

U2 - 10.1017/S0317167100014232

DO - 10.1017/S0317167100014232

M3 - Review article

C2 - 23603164

AN - SCOPUS:84893334996

VL - 40

SP - 299

EP - 306

JO - Canadian Journal of Neurological Sciences

JF - Canadian Journal of Neurological Sciences

SN - 0317-1671

IS - 3

ER -